[
1. IDF Diabetes Atlas 7th Edition 2015. Available: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/13-diabetes-atlas-seventh-edition.html
]Search in Google Scholar
[
2. Blair M. Diabetes Mellitus Review. Urol Nurs. 2016;36(1):27-36.10.7257/1053-816X.2016.36.1.27
]Search in Google Scholar
[
3. Brealey D, Singer M. Hyperglycemia in critical illness: a review. J Diabetes Sci Technol. 2009;3(6):1250-60.10.1177/193229680900300604278702420144378
]Search in Google Scholar
[
4. Dias DA, Urban S, Roessner U. A Historical Overview of Natural Products in Drug Discovery. Metabolites. 2012;2(2):303-36.10.3390/metabo2020303390120624957513
]Search in Google Scholar
[
5. Chang CL, Chen YC, Chen HM, et al. Natural cures for type 1 diabetes: a review of phytochemicals, biological actions, and clinical potential. Curr Med Chem. 2013;20(7):899-907.10.2174/0929867311320070006
]Search in Google Scholar
[
6. Yeh GY, Eisenberg DM, Kaptchuk TJ, et al. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003;26(4):1277-94.10.2337/diacare.26.4.127712663610
]Search in Google Scholar
[
7. Covington MB. Traditional Chinese medicine in the treatment of diabetes. Diabetes Spectr. 2001;14:154-9.10.2337/diaspect.14.3.154
]Search in Google Scholar
[
8. Ota A, Ulrih NP. An overview of herbal products and secondary metabolites used for management of type two diabetes. Front Pharmacol. 2017;8:436.10.3389/fphar.2017.00436549930828729836
]Search in Google Scholar
[
9. Pandey VN, Rajagopalan SS, Chowdhary DP. An effective Ayurvedic hypoglycemic formulation. J Res Ayurveda Siddha. 1995;1-14.
]Search in Google Scholar
[
10. Oubre AY, Carlson TJ, King SR, et al. From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM. Diabetologia. 1997;40:614-17.10.1007/s0012500507249165233
]Search in Google Scholar
[
11. Karimi A, Majlesi M, Rafieian-Kopaei M. Herbal versus synthetic drugs; beliefs and facts. J Nephropharmacol. 2015;4(1):27-30.
]Search in Google Scholar
[
12. Bharti SK, Krishnan S, Kumar A, et al. Antidiabetic phyto-constituents and their mode of action on metabolic pathways. Ther Adv Endocrinol Metab. 2018;9(3):81-100.10.1177/2042018818755019581385929492244
]Search in Google Scholar
[
13. Chávez-Mendoza C, Sánchez E. Bioactive compounds from Mexican varieties of the Common Bean (Phaseolus vulgaris): implications for health. Molecules. 2017;22(8),1360.10.3390/molecules22081360
]Search in Google Scholar
[
14. Reynoso-Camacho R., Ramos-Gomez M., Loarca-Pina G. Bioactive components in common beans (Phaseolus vulgaris L.). Research Signpost. 2006;37/661(2):217-36.
]Search in Google Scholar
[
15. Helmstädter A. Beans and diabetes: Phaseolus vulgaris preparations as antihyperglycemic agents. J Med Food. 2010;13(2):251-4.10.1089/jmf.2009.000220132042
]Search in Google Scholar
[
16. Zafar M, Naqvi S. Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in Albino rats: A comparative study. Int J Morphol. 2010;28(1):135-42.10.4067/S0717-95022010000100019
]Search in Google Scholar
[
17. Sabu MC, Subburaju T. Effect of Cassia auriculata Linn. on serum glucose level, glucose utilization by isolated rat hemidiaphragm. J Ethnopharmacol. 2002;80:203-6.10.1016/S0378-8741(02)00026-0
]Search in Google Scholar
[
18. Stasevych M, Zvarych V, Lunin V, et al. Novel anthraquinone-based derivatives as potent inhibitors for receptor tyrosine kinases. Indian J Pharm Sci. 2015;77(5):634-7.10.4103/0250-474X.169062
]Search in Google Scholar
[
19. Carai MAM, Fantini N, Loi B, et al. Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism. Diabetes Metab Syndr Obes. 2009;2:145-53.10.2147/DMSO.S4236
]Search in Google Scholar
[
20. Roman-Ramos R, Flores-Saenz JL, Partida-Hernandez G, et al. Experimental study of the hypoglycemic effect of some edible plants. Arch Invest Med (Mex). 1991;22:87-93.
]Search in Google Scholar
[
21. Roman-Ramos R, Flores-Saenz JL, Alarcon-Aguilar F. Antihyperglycemic effect of some edible plants. J Ethnopharmacol. 1995;48:25-32.10.1016/0378-8741(95)01279-M
]Search in Google Scholar
[
22. Pari L, Venkateswaran S. Effect of an aqueous extract of Phaseolus vulgaris on plasma insulin and hepatic key enzymes of glucose metabolism in experimental diabetes. Pharmazie. 2003;58:916-9.
]Search in Google Scholar
[
23. Almuaigela MF, Seifb MA, Albualia HW, Alharbia O, Alhawasha A. Hypoglycemic and hypolipidemic effects of aqueous extract of phaseolus vulgaris pods in streptozotocin-diabetic rats. Biomedicine & Pharmacotherapy. 2017; 94:742-6.10.1016/j.biopha.2017.07.13528800543
]Search in Google Scholar
[
24. Pari L, Venkateswaran S. Protective role of Phaseolus vulgaris on changes in the fatty acid composition in experimental diabetes. J Med Food. 2004;7(2):204-9.10.1089/109662004122412015298769
]Search in Google Scholar
[
25. Neef H, Declercq P, Laekeman G. Hypoglycemic activity of selected European plants. Phytother Res. 1995;9:45-8.10.1002/ptr.2650090111
]Search in Google Scholar
[
26. Cerovic A, Miletic I, Konic.-Ristic A, et al. The dry plant extract of common bean seed (Phaseoli vulgari pericarpium) does not have an affect on postprandial glycemia in healthy human subject. Bosn J Basic Med Sci. 2006;6(3):28-33.10.17305/bjbms.2006.3140719365716995844
]Search in Google Scholar
[
27. Kyznetsova MY, Lavrovska DO, Zhyvolozhnyi AY, et al. Effect of aqueous extract from Phaseolus vulgaris pods on cytokine profile of streptozotocin-induced diabetic rats. RJPBCS. 2015;6(1):1511-20.
]Search in Google Scholar
[
28. Kyznietsova MY, Halenova TI, Savchuk OM, et al. Carbohydrate metabolism in type 1 diabetic rats under the conditions of the kidney bean pods aqueous extract application. Fiziol Zh. 2015;61(6):96-103.10.15407/fz61.06.09627025050
]Search in Google Scholar
[
29. Kyznetsova M, Makieieva O, Lavrovska D, et al. Aqueous extract from Phaseolus vulgaris pods on lipid peroxidation and antioxidant enzymes activity in the liver and kidney of diabetic rats. J Appl Pharm Sci. 2015; 5(5):001-6.10.7324/JAPS.2015.50501
]Search in Google Scholar
[
30. Oseguera Toledo ME, Gonzalez de Mejia E, Sivaguru M, et al. Common bean (Phaseolus vulgaris L.) protein-derived peptides increased insulin secretion, inhibited lipid accumulation, increased glucose uptake and reduced the phosphatase and tensin homologue activation in vitro. J Funct Foods. 2016; 27:160-77.10.1016/j.jff.2016.09.001
]Search in Google Scholar
[
31. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51(2):216-26.10.1007/s00125-007-0886-718087688
]Search in Google Scholar
[
32. Lim M, Park L, Shin G, Hong H, Kang I, Park Y. Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus. Ann NY Acad Sci. 2008;1150:311-5.10.1196/annals.1447.01119120318
]Search in Google Scholar
[
33. Barrett ML, Udani JK. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Nutr J. 2011;10:24.10.1186/1475-2891-10-24307177821414227
]Search in Google Scholar
[
34. Baintner K, Kiss P, Pfüller U, et al. Effect of orally and intraperitoneally administered plant lectins on food consumption of rats. Acta Physiol Hung. 2003; 90(2):97-107.10.1556/APhysiol.90.2003.2.212903908
]Search in Google Scholar